---
figid: PMC5362109__nihms829632f2
figlink: /pmc/articles/PMC5362109/figure/F2/
number: F2
caption: Autoimmunity in vitiligo is driven by the IFN-γ-CXCL10 cytokine signaling
  pathway. Activated melanocyte-specific CD8+ T cells secrete IFN-γ, which signals
  through the IFN-γ receptor (IFN-γR) to activate JAK1/2 and STAT1. This induces the
  production of CXCL9 and CXCL10, which signal through their receptor CXCR3 to recruit
  more autoreactive T cells to the epidermis, resulting in widespread melanocyte destruction.
  Targeting this cytokine pathway represents an emerging treatment strategy for vitiligo.
pmcid: PMC5362109
papertitle: Vitiligo pathogenesis and emerging treatments.
reftext: Mehdi Rashighi, et al. Dermatol Clin. ;35(2):257-265.
pmc_ranked_result_index: '70045'
pathway_score: 0.9547589
filename: nihms829632f2.jpg
figtitle: Autoimmunity in vitiligo is driven by the IFN-Gamma-CXCL10 cytokine signaling
  pathway
year: ''
organisms: Homo sapiens
ndex: c7b21d5e-dee4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5362109__nihms829632f2.html
  '@type': Dataset
  description: Autoimmunity in vitiligo is driven by the IFN-γ-CXCL10 cytokine signaling
    pathway. Activated melanocyte-specific CD8+ T cells secrete IFN-γ, which signals
    through the IFN-γ receptor (IFN-γR) to activate JAK1/2 and STAT1. This induces
    the production of CXCL9 and CXCL10, which signal through their receptor CXCR3
    to recruit more autoreactive T cells to the epidermis, resulting in widespread
    melanocyte destruction. Targeting this cytokine pathway represents an emerging
    treatment strategy for vitiligo.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD8A
  - CXCR3
  - JAK1
  - CXCL9
  - TYK2
  - CD8B
  - JAK2
  - JAK3
  - CXCL10
genes:
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CXCR3
  symbol: CXCR3
  source: hgnc_symbol
  hgnc_symbol: CXCR3
  entrez: '2833'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: CXCL9
  symbol: CXCL9
  source: hgnc_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: CXCL10
  symbol: CXCL10
  source: hgnc_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
chemicals: []
diseases: []
figid_alias: PMC5362109__F2
redirect_from: /figures/PMC5362109__F2
figtype: Figure
---
